Skip to main content

Table 3 Factors associated with compliance during the study

From: Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study

Variables

Value

Odds ratio

95% CI

pvalue (vs reference)

pvalue (overall)

Compliance at baseline

Low (<80%)

1

Reference

 

<0.001

High (80% to 100%)

6.91

[5.04, 9.46]

<0.001

 

Country

    

<0.001

Length of initial treatment

>90 days

1

Reference

 

0.014

31 to 90 days

0.74

[0.54, 1.03]

0.073

 

30 days or fewer

1.42

[0.89, 2.27]

0.14

 

Insight into illness at baseline

Moderate

1

Reference

 

<0.001

Low/none

0.33

[0.20, 0.56]

<0.001

 

Medium

0.94

[0.65, 1.35]

0.73

 

High

2.79

[1.87, 4.18]

<0.001

 

Number of days the patient used day hospital

 

0.99

[0.98, 0.99]

 

0.002

Satisfaction with life during study

Very satisfied

1

Reference

 

0.002

Satisfied

0.65

[0.48, 0.88]

0.006

 

Neither satisfied nor dissatisfied

0.56

[0.37, 0.83]

0.004

 

Dissatisfied

0.39

[0.24, 0.62]

<0.001

 

Very dissatisfied

0.81

[0.39, 1.67]

0.57

 

Impairment in work activities during study

Severe

1

Reference

 

0.007

Moderate

0.91

[0.53, 1.57]

0.75

 

Mild

1.15

[0.69, 1.92]

0.59

 

No

1.64

[0.92, 2.92]

0.09

 

Time of observation

Per visit

   

0.013

  1. CI, confidence interval.